Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
160 Health InternationalHKSE:02656 -2.87%8 Days Payable is 77.00 as of Dec. 2025, which is 12% above its 10-year median of 68.45. GuruFocus rates HKSE:02656 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 117 Medical Distribution companies, 160 Health International ranks better than 52.99% on this metric.
The historical rank and industry rank for 160 Health International's Days Payable or its related term are showing as below:
HKSE:02656'
s Days Payable Range Over the Past 10 Years
Min: 50.32 Med: 68.45 Max: 83.26
Current: 79.81
During the past 4 years, 160 Health International's highest Days Payable was 83.26. The lowest was 50.32. And the median was 68.45.
HKSE:02656's Days Payable is ranked better than 52.99% of 117
companies
in the Medical Distribution industry
Industry Median: 76.55
vs HKSE:02656: 79.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02656 vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, 160 Health International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
160 Health International Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 160 Health International's Days Payable distribution charts can be found below:
* The bar in red indicates where 160 Health International's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
160 Health International's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
160 Health International (HKSE:02656) has a Days Payable of 77.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 160 Health International and its competitors. This is 12% above median its historical median of 68.45. Over the past decade, 160 Health International's Days Payable has ranged from 50.32 to 83.26. According to the industry distribution chart, 160 Health International ranks #55 out of 117 companies in the Medical Distribution industry, placing it in the top 47%.
Is 160 Health International's Days Payable too high?
160 Health International's current Days Payable of 77.00 is 12% above median its 10-year median of 68.45. Over the past 10 years, this metric has ranged from a low of 50.32 to a high of 83.26. The Medical Distribution industry median Days Payable is 76.55. 160 Health International's value of 77.00 is 0.6% above this industry median. Based on the distribution chart, 160 Health International ranks #55 out of 117 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, 160 Health International ranks #55 out of 117 companies for Days Payable. This puts 160 Health International in the upper half of its industry. The industry median Days Payable is 76.55. 160 Health International's value of 77.00 is 0.6% above this benchmark. Historically, 160 Health International's own Days Payable has ranged from 50.32 to 83.26 over the past decade. While the company's 10-year median is 68.45 vs. the industry median of 76.55, 160 Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 76.55, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 160 Health International's current Days Payable of 77.00 is 0.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 160 Health International and its competitors. For the Medical Distribution industry, the median Days Payable is 76.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 160 Health International's current Days Payable is 77.00, which is 12% above median its own 10-year median of 68.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (HKSE:02656) has a current Days Payable of 77.00. The current Days Payable is 77.00, which is 12% above median its 10-year median of 68.45 and 0.6% above the Medical Distribution industry median of 76.55. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For 160 Health International (HKSE:02656), the current Days Payable is 77.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score
Get the complete analysis for HKSE:02656
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02656 has been successfully added to your 
